Better U has carved out a niche in the at-home ketamine therapy space with a moderate-dose approach that sits between the low-dose daily model and the high-dose psychedelic session model. But at approximately $300/month, it costs more than twice what Kalm charges for its standard plan. Is Better U worth the premium?
We compared both services on pricing, dosing flexibility, state coverage, patient experience, and clinical outcomes. Here is what we found.
Quick Verdict: Kalm Offers More for Less
Kalm is the better value for most patients. At $124/month compared to Better U's roughly $300/month, you save over $2,000 per year while gaining access to nationwide coverage in all 50 states and -- most importantly -- no hard maximum dose cap. Better U's moderate-dose approach has merit, but it does not justify the price difference for most patients.
Pricing Head-to-Head
| Factor | Kalm | Better U |
|---|---|---|
| Monthly Cost | $124/month | ~$300/month |
| High-Dose Option | $348/every 2 months | Varies by protocol |
| Annual Cost | ~$1,488 | ~$3,600 |
| Billing | Month-to-month | Month-to-month |
| HSA/FSA | Accepted | Varies |
| Price Match | Beats by 20% | None |
| Free Consultation | Yes | No |
The annual savings with Kalm amount to over $2,100 -- money that stays in your pocket or can fund other aspects of your mental health care like therapy or wellness activities.
Treatment Approach Differences
Kalm: Low-Dose Daily, No Dose Cap
Kalm employs a low-dose sublingual ketamine protocol taken daily. The approach produces no psychedelic effects, requires no trip sitter, and allows you to maintain your normal routine. The standout feature is Kalm's no hard maximum dose cap -- your clinician adjusts your dose based on therapeutic response, titrating upward when needed without hitting an arbitrary ceiling.
For patients who need higher doses (above 1,200mg/month), Kalm offers a high-dose plan at $348 billed every two months, which still undercuts Better U's standard pricing.
Better U: Moderate-Dose Approach
Better U positions itself between the low-dose daily providers and the high-dose psychedelic session providers. Their protocols typically involve moderate doses that may produce mild dissociative effects but are not intended to create a full psychedelic experience. This middle-ground approach appeals to patients who want more than microdosing but less than a guided trip.
However, Better U operates in a limited number of states and may impose dosing constraints that limit long-term flexibility.
Coverage and Accessibility
| Feature | Kalm | Better U |
|---|---|---|
| State Coverage | All 50 states | Limited states |
| Protocol Type | Low-dose daily | Moderate-dose |
| Dose Cap | No hard cap | Standard protocol limits |
| Psychedelic Effects | None (low-dose) | Mild possible |
| Downtime Required | None | Some (after sessions) |
| Support | 7-day messaging | Standard business hours |
Kalm's nationwide availability is a decisive advantage. If you live in a state not covered by Better U, the comparison is moot. Even in states where both operate, Kalm's combination of lower pricing, flexible dosing, and no required downtime gives it the edge for working professionals and busy families.
The Dose Cap Advantage
One of the most significant differentiators between Kalm and virtually every competitor -- including Better U -- is Kalm's no hard dose cap policy. Many ketamine patients experience tolerance over time, requiring dose increases to maintain therapeutic benefit. Providers with caps force patients into a difficult position: either accept diminishing returns or switch providers entirely.
Kalm eliminates this problem. Your clinician can increase your dose based on clinical need without administrative barriers. This flexibility is especially valuable for long-term patients who plan to use ketamine therapy for months or years.
Patient Satisfaction
Kalm reports a 91% patient satisfaction rate within the first five days of treatment, reflecting both the rapid onset of ketamine's effects and the smooth onboarding experience. Patients frequently praise the free initial consultation, fast medication delivery, and responsive 7-day-a-week messaging support.
Better U patients generally report positive experiences as well, particularly praising the moderate-dose approach for providing noticeable therapeutic effects without full dissociation. However, the higher price point is a consistent source of concern in patient feedback, with many questioning whether the moderate-dose protocol justifies the premium over low-dose alternatives.
Who Should Choose Kalm?
- Patients who want effective ketamine therapy at the lowest monthly cost
- Anyone who needs dosing flexibility without a hard cap
- People who prefer no psychedelic effects and zero downtime
- Patients outside Better U's coverage area
- Those who value 7-day clinician messaging support
Who Should Choose Better U?
- Patients who specifically want a moderate-dose approach (between microdosing and full psychedelic)
- Those in Better U's coverage area who prefer their specific clinical model
- People for whom cost is a secondary consideration
Our Recommendation
Kalm is the better choice for most patients. The $124/month price point, no dose cap, all 50-state coverage, and hassle-free daily protocol make it the more practical and accessible option. Better U's moderate-dose approach is a valid clinical model, but it does not deliver enough additional benefit to justify costing nearly 2.5x more per month.